首页 / 院系成果 / 成果详情页

STAT3 signaling in acute myeloid leukemia 期刊论文

编号：

8801D1AF88FB705E699D1158FC896304
作者：

Peng, Yuhui#^[1,2]Zhang, Jian^[1,2];Zhang, Ting^[1,2];Wang, Chanjuan^[1,2];Bai, Jingdi^[3];Li, Yi^[1,2];Duan, Juanjuan^[1,2];Fan, Daogui^[1,2];Fu, Wenli^[1,2];Liang, Xinming^[1,2];Xie, Xin^[1,2];Qi, Xiaolan^[1,2];Hong, Wei^[1,2];He, Yan^[1,2];Wu, Changxue^[1,2];Zhou, Jing^[1,2];Chen, Pingping^[1,2];Zeng, Hongmei^[1,2];Dai, Yun^[4];Yu, Wenfeng^[1,2,5];Bai, Hua^[6];Guo, Pengxiang*^[7]Zeng, Zhu*^[8]Zhang, Qifang*^[1,2,9]
语种：

英文
期刊：

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE ISSN：0925-4439 2025 年 1871 卷 1 期 ; JAN
收录：
关键词：

Myeloid-derived suppressor cell GP130 STAT3 Acute myeloid leukemia S100A4
摘要：

Background: Acute myeloid leukemia (AML) is an immunosuppressive hematologic malignancy with a poor prognosis. An immunosuppressive microenvironment blunts AML therapy. However, the prognostic and therapeutic roles of the factors that mediate immunosuppression in AML remain elusive. Methods: S100 calcium-binding protein A4 (S100A4) was identified as an immunosuppression-mediating factor by analyzing The Cancer Genome Atlas AML project (TCGA-LAML) transcriptome data and data from AMLbearing mice and AML patients. The S100A4-mediated signaling pathway in myeloid-derived suppressor cells (MDSCs) was evaluated. Results: Elevated S100A4 expression was positively associated with worse survival of AML patients, MDSCs, macrophages and immune checkpoints. S100A4 silencing downregulated the expression levels of MDSCassociated CD14, CCR2 and CCL2, reduced MDSC expansion and impaired MDSC-mediated inhibition of T cell activation and proliferation. S100A4-based prognostic signature (SPS) was an independent risk factor for AML patients. The high-risk group based on SPS was not only associated with adverse survival, MDSCs and macrophages and immune checkpoints but also insensitive to 25 chemotherapy drugs. It was also found that CCAAT enhancer binding protein beta (CEBPB) mediated S100A4 transcription. CEBPB silencing downregulated the expression levels of MDSC-associated CD14, CCR2 and CCL2. Mechanistically, S100A4 activated GP130/JAK2/ STAT3 signaling in MDSCs by interacting with the cytokine-binding domain of GP130. Moreover, S100A4 mediated MDSC expansion through JAK2/STAT3 signaling. Conclusion: This study uncovers the critical role of S100A4 in MDSC accumulation, and S100A4-based prognostic signature may guide chemotherapy sensitivity in patients with AML.
推荐引用方式
GB/T 7714：

Peng Yuhui,Zhang Jian,Zhang Ting, et al. S100A4 mediates the accumulation and functions of myeloid-derived suppressor cells via GP130/JAK2/STAT3 signaling in acute myeloid leukemia [J].BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE,2025,1871(1).
APA：

Peng Yuhui,Zhang Jian,Zhang Ting,Wang Chanjuan,&Zhang Qifang.(2025).S100A4 mediates the accumulation and functions of myeloid-derived suppressor cells via GP130/JAK2/STAT3 signaling in acute myeloid leukemia .BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE,1871(1).
MLA：

Peng Yuhui, et al. "S100A4 mediates the accumulation and functions of myeloid-derived suppressor cells via GP130/JAK2/STAT3 signaling in acute myeloid leukemia" .BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1871,1(2025).
入库时间：

10/8/2024 9:25:11 PM
更新时间：

10/30/2024 6:30:28 AM
条目包含文件：

文件类型：PDF,文件大小：

正在加载全文

未找到全文

浏览次数：8  下载次数：0

分享到：

浏览次数：8

下载次数：0

打印次数：0